U.S. Banks Stock News

Tempus AI recently reported results from its ALERT trial, showing that AI-driven electronic health record alerts improved timely evaluation and treatment for patients with significant aortic stenosis and mitral regurgitation across five U.S. health systems. By using natural language processing to scan echocardiogram reports and automatically notify clinicians, the ALERT platform not only boosted rates of specialist evaluation and valve procedures but also highlighted how AI tools might...

Prosperity Bancshares (PB) is back in focus after two catalysts: fresh analyst rating changes tied to macro and sector risks, and a sizable new position from institutional investor Artisan Partners. See our latest analysis for Prosperity Bancshares. At a share price of US$67.02, Prosperity Bancshares has seen a 2.5% 7 day share price return but a 3.8% year to date share price decline. The 1 year total shareholder return of 7.6% and 3 year total shareholder return of 22.7% point to steadier...

What Tyson Foods stock data suggests right now Tyson Foods (TSN) has recently attracted attention as investors reassess the business using its latest reported figures, including US$55.1b in revenue, US$200m in net income, and a market value near US$22.8b. See our latest analysis for Tyson Foods. The share price sits at US$64.63, with a 30-day share price return of 4.14% and a 90-day share price return of 11.35%. The 1-year total shareholder return of 11.88% and 3-year total shareholder return...

In recent days, UL Solutions reported strong fourth-quarter 2025 results that exceeded earnings estimates with year-over-year revenue growth, while CEO Jennifer F. Scanlon completed over US$1,000,000 of share sales tied to equity awards and performance cash settlements. The company also delivered a first-of-its-kind safety certification for Simbe’s Tally autonomous shelf-scanning robot under the UL 3300 standard, underscoring its role in setting benchmarks for emerging public-use robotics...

ArriVent BioPharma (AVBP) has drawn attention after recent trading, with the share price closing at US$24.89. Investors are weighing this clinical stage cancer drug developer’s profile against its current valuation signals. See our latest analysis for ArriVent BioPharma. That closing share price of US$24.89 comes after a 2.77% 1 day share price return and a 16.15% 7 day share price return. The 30 day share price return of 1.43% contrasts with a 19.66% 90 day share price return and a 51.58% 1...

In late March 2026, Illinois Tool Works Inc. disclosed a shareholder proposal from John Chevedden seeking mandatory board departure for any director who fails to secure a majority vote in an uncontested election, with a maximum nine‑month transition period after such a result. At the same time, Illinois Tool Works reported quarterly earnings per share of US$2.72 and issued an upbeat 2026 EPS outlook of US$11.00–US$11.40, reinforcing management’s confidence in its operations while the board...

Home Depot (HD) is back in focus after naming artificial intelligence expert Dr. Franziska Bell as chief technology officer and striking a new online product partnership with AXIL Brands on HomeDepot.com. See our latest analysis for Home Depot. Despite the fresh AI push and new partnerships, Home Depot’s share price has seen a 30-day share price return decline of 11.07% and a year-to-date share price return decline of 7%, while the 3-year total shareholder return of 20.21% points to a...

How recent earnings and new products frame General Mills stock General Mills (GIS) has been in focus after missing earnings expectations and reporting a year over year revenue decline, while at the same time rolling out new branded cereals and keeping its quarterly dividend unchanged. For you as an investor, that mix of weaker recent results, resilient shareholder payouts and fresh product launches raises a practical question: is the current share price, recent performance and income profile...

Royalty Pharma (NasdaqGS:RPRX) has entered into a new R&D co-funding agreement with Johnson & Johnson to develop a novel autoimmune therapy. The company has also appointed a Head of Artificial Intelligence to expand the use of advanced analytics and data science across its operations. These announcements mark a shift toward greater involvement in drug development and data driven decision making. Royalty Pharma, known primarily for acquiring biopharma royalties, typically gives investors...

In late March 2026, Ingredion announced a three-year partnership with CIBO Technologies to support regenerative agriculture across its supply chains, alongside appointing long-time executive Jason Payant as Interim Chief Financial Officer and adding former Glanbia CEO Siobhán Talbot to its Board. These moves suggest Ingredion is tightening financial stewardship while deepening its commitment to traceable, sustainable sourcing that could matter to large consumer goods customers. We’ll now...

DoorDash (DASH) is back in focus after signing a multi year partnership with ALSO, a Rivian spinoff, and investing in its Series C round to co develop autonomous last mile delivery using purpose built small electric vehicles. See our latest analysis for DoorDash. The ALSO agreement lands during a choppy stretch for the stock, with a 1 day share price return of 3.95% and 7 day share price return of 6.72%, offset by a 30 day share price return decline of 14.73% and a year to date share price...

Wondering if Slide Insurance Holdings is priced fairly or offering value right now? This article walks through what the current numbers actually say. The share price last closed at US$18.00, with a 2.5% return over the past 7 days and a 7.6% decline over the past 30 days, leaving the year to date return at a 3.0% decline. Recent price moves are occurring as Slide Insurance Holdings continues to attract attention as a listed insurance name in the US market. Investors are weighing its growth...

Wondering if Adams Diversified Equity Fund is priced attractively after its recent run, or if most of the value is already reflected in the share price? The stock last closed at US$22.43, with a 5.3% return over 7 days, compared with a 2.6% decline over 30 days and a 3.5% decline year to date. The 1 year and 3 year returns sit at 40.2% and 93.9% respectively, and 5 year returns at 97.3%. Recent news coverage around Adams Diversified Equity Fund has focused on its role as a long running,...

Why FactSet Research Systems (FDS) is Back on Investors’ Radar FactSet Research Systems (FDS) has drawn fresh attention after recent trading left the shares around $227.68, with returns showing mixed signals across the past week, month, and past 3 months. See our latest analysis for FactSet Research Systems. The recent 14.8% 7 day share price return contrasts with a 20.1% decline year to date and a 44.5% 1 year total shareholder return loss. This suggests short term momentum after a tougher...

In recent weeks, Crescent Energy’s position as a top 10 independent U.S. oil and gas producer has been reinforced by its multi–billion‑dollar Vital Energy acquisition and stronger investor attention amid heightened Middle East tensions that have lifted crude prices and earnings expectations across the sector. The combination of a larger Permian-focused asset base, rising free cash flow, and an expanding royalties business is now reshaping how Crescent Energy is grouped and compared within...

Rithm Capital (RITM) is back in focus after its board declared first quarter 2026 dividends across both preferred and common shares, a move that ties directly into its income-focused real estate finance model. See our latest analysis for Rithm Capital. At a share price of $9.63, Rithm has seen short term share price pressure with a 90 day share price return of a 12.3% decline, while the 3 year total shareholder return of 59.57% points to stronger longer term momentum. If this income story has...

In late March 2026, Micron Technology completed cash tender offers for six series of senior notes maturing between 2031 and 2035, with investors tendering the vast majority of the outstanding principal and Micron expecting to pay for accepted notes on April 3, 2026. This large-scale debt repurchase, alongside record AI-driven earnings and sold-out high-bandwidth memory capacity, highlights Micron’s active balance sheet management as it leans into heightened demand for advanced memory. We’ll...

Regulators allowed the Hart Scott Rodino antitrust waiting period for Coterra Energy's merger with Devon Energy to expire, clearing a key hurdle. This approval means Coterra Energy (NYSE:CTRA) can move toward closing, with the company expected to become a wholly owned subsidiary of Devon. The companies currently anticipate closing the transaction in Q2 2026, subject to remaining customary conditions. Coterra Energy focuses on oil and gas exploration and production, an area where scale, cost...

In late March 2026, Credo Technology Group Holding Ltd reached confidential cross‑license and settlement agreements with both TE Connectivity and Molex, leading to the prompt dismissal of all AEC‑related patent lawsuits between the companies. By clearing these legal overhangs while advancing its ZeroFlap connectivity solutions for AI data centers, Credo is tightening its focus on scaling core AEC and optical technologies for hyperscaler customers. We’ll now examine how resolving these AEC...

Recent performance snapshot With no single fresh headline driving attention today, Coinbase Global (COIN) is back in focus as investors reassess the stock after a one-month return decline of 17% and a past three-month return decline of 28%. See our latest analysis for Coinbase Global. The recent 7 day share price return of 6.4% sits against a weaker backdrop, with a 30 day share price return of a 16.6% decline and a year-to-date share price return of a 27.5% decline. At the same time, the 3...

Royal Caribbean Cruises (RCL) is in focus after partnering with Bank of America on Royal ONE and Royal ONE Plus, new tri branded credit cards that tie together rewards across its cruise brands. See our latest analysis for Royal Caribbean Cruises. The new Royal ONE credit cards arrive as Royal Caribbean’s share price has eased 3.4% over the past 90 days but still sits at US$273.59, with a 1 year total shareholder return of 56% and a very large 3 year total shareholder return, suggesting long...

PVH Corp (PVH) is back in focus after Q4 results topped expectations, with Calvin Klein and Tommy Hilfiger driving revenue, direct to consumer channels reaching 50% of sales, and tariff mitigation efforts easing investor concerns. See our latest analysis for PVH. The Q4 beat and upbeat 2026 outlook have coincided with strong short term momentum, with a 7 day share price return of 16.1% and a 1 year total shareholder return of 14.1%. However, the 5 year total shareholder return shows a 29.6%...

Why Arthur J. Gallagher stock is drawing closer investor attention Arthur J. Gallagher (AJG) has been attracting closer attention after a period where the share price has moved differently across timeframes, with gains over the past week set against weaker month and past 3 months returns. See our latest analysis for Arthur J. Gallagher. The recent 5.07% 7 day share price return contrasts with a weaker 30 day and year to date share price performance, while the 1 year total shareholder return...

Wix.com (NasdaqGS:WIX) completed a modified Dutch auction share repurchase, buying back nearly 30% of its outstanding shares. The buyback reduces Wix's share count and follows a period of increased focus on AI driven product investments. The transaction comes as some analysts lower their ratings on the stock, even as the company continues to invest in growth initiatives. Wix.com runs a global website creation and business management platform used by individuals, small businesses, and larger...